Siegfried Annual Report 2009

Prof. Felix Gutzwiller, M.D.
Felix Gutzwiller (1948) joined the Board of Siegfried Holding
AG in 1999. Since 1988 he is a professor and head of the
Preventive Medicine Department at the University of Zurich.
He is a member of the Swiss Parlament (Senate).
Felix Gutzwiller completed his studies at the universities
of Basel, Harvard, and Johns Hopkins (U.S.A.).
In addition to Siegfried Holding AG, Felix Gutzwiller is also
on the Boards of Rahn AG, Medi-Clinic (Switzerland) AG,
Bank Clariden Leu AG, Axa Winterthur Schweiz AG, and
Osiris Therapeutics, Inc. He serves on the Board of Trustees
of numerous charity, scientific and public health foundations.
Felix Gutzwiller is a Colonel in the Swiss Army.
Felix Gutzwiller is a Swiss citizen.
Felix K. Meyer, Ph.D.
Felix K. Meyer (1953) joined the Board of Siegfried Holding
AG in 2006. He worked for Ciba-Geigy AG (later Ciba
Specialty Chemicals) from 1981-2004, and held various positions
in Switzerland and abroad, ultimately, as a Segment
Manager and member of the Board. During this time he focused
corporate strategy and marketing issues, representing
the company in joint ventures in Europe and Asia (China and
Japan). From 2004 to 2009, Felix K. Meyer was CEO of the
Baerlocher Group, a global specialty chemicals company
with headquarters in Munich, Germany.
Since January 2010, he is a member of the advisory board
of the Baerlocher Group.
He received his Ph.D. in Chemical Engineering from the
ETH in Lausanne, Switzerland and spent a year in Stanford
University (U.S.A.) as a Post-doctoral Fellow.
Felix K. Meyer is a Swiss citizen.
22 Corporate Governance